Abstract
Endothelial cells are major constituents in the vasculature, and they act as important players in vascular homeostasis via secretion/release of vasodilators and vasoconstrictors. In healthy arteries, endothelial cells play a key role in the regulation of vascular tone, cellular adhesion, and angiogenesis. A shift in the functions of the blood vessels toward vasoconstriction, proinflammatory state, oxidative stress and deficiency of nitric oxide (NO) might lead to endothelial dysfunction, a key event implicated in the pathophysiology of cardiovascular metabolic diseases, including diabetes, atherosclerosis, arterial hypertension and pulmonary arterial hypertension (PAH). Thus, reversibility of endothelial dysfunction may be beneficial for maintaining vascular homeostasis. In recent years, accumulative evidence has documented that noncoding RNAs (ncRNAs) are critically involved in endothelial homeostasis. Specifically, long noncoding RNAs (lncRNAs) and circular RNAs are highly expressed in endothelial cells where they serve as important mediators in normal endothelial functions. Dysregulation of lncRNAs and circular RNAs has been tightly associated with hypertension-related endothelial dysfunction. In this review, we will summarize the current progression and underlying mechanisms of lncRNA and circular RNA in endothelial cell biology under hypertensive conditions. We will also highlight their potential as biomarkers or therapeutic targets for hypertension and its associated endothelial dysfunction.
Similar content being viewed by others
References
Roth GA, Nguyen G, Forouzanfar MH, Mokdad AH, Naghavi M, Murray CJ (2015) Estimates of global and regional premature cardiovascular mortality in 2025. Circulation 132:1270–1282. https://doi.org/10.1161/circulationaha.115.016021
Metra M, Teerlink JR (2017) Heart failure. Lancet 390:1981–1995. https://doi.org/10.1016/s0140-6736(17)31071-1
Travieso-Gonzalez A, Nunez-Gil IJ, Riha H, Donaire JAG, Ramakrishna H (2019) Management of arterial hypertension: 2018 ACC/AHA versus ESC guidelines and perioperative implications. J Cardiothorac Vasc Anesth 33:3496–3503. https://doi.org/10.1053/j.jvca.2019.03.068
Southgate L, Machado RD (2020) Molecular genetic framework underlying pulmonary arterial hypertension. Nat Rev Cardiol 17:85–95. https://doi.org/10.1038/s41569-019-0242-x
Thompson AAR, Lawrie A (2017) Targeting vascular remodeling to treat pulmonary arterial hypertension. Trends Mol Med 23:31–45. https://doi.org/10.1016/j.molmed.2016.11.005
Leopold JA, Maron BA (2016) Molecular mechanisms of pulmonary vascular remodeling in pulmonary arterial hypertension. Int J Mol Sci. https://doi.org/10.3390/ijms17050761
Sun HJ, Zhu XX, Cai WW, Qiu LY (2017) Functional roles of exosomes in cardiovascular disorders: a systematic review. Eur Rev Med Pharmacol Sci 21:5197–5206. https://doi.org/10.26355/eurrev_201711_13840
Ghosh A, Gao L, Thakur A, Siu PM, Lai CWK (2017) Role of free fatty acids in endothelial dysfunction. J Biomed Sci 24:50. https://doi.org/10.1186/s12929-017-0357-5
Liu L, Liu J, Huang Y (2015) Protective effects of glucagon-like peptide 1 on endothelial function in hypertension. J Cardiovasc Pharmacol 65:399–405. https://doi.org/10.1097/fjc.0000000000000176
Konukoglu D, Uzun H (2017) Endothelial dysfunction and hypertension. Adv Exp Med Biol 956:511–540. https://doi.org/10.1007/5584_2016_90
Dodson MW, Brown LM, Elliott CG (2018) Pulmonary arterial hypertension. Heart Fail Clin 14:255–269. https://doi.org/10.1016/j.hfc.2018.02.003
Sun HJ, Hou B, Wang X, Zhu XX, Li KX, Qiu LY (2016) Endothelial dysfunction and cardiometabolic diseases: role of long non-coding RNAs. Life Sci 167:6–11. https://doi.org/10.1016/j.lfs.2016.11.005
Zhang HN, Xu QQ, Thakur A, Alfred MO, Chakraborty M, Ghosh A, Yu XB (2018) Endothelial dysfunction in diabetes and hypertension: role of microRNAs and long non-coding RNAs. Life Sci 213:258–268. https://doi.org/10.1016/j.lfs.2018.10.028
Sauvageau M, Goff LA, Lodato S, Bonev B, Groff AF, Gerhardinger C, Sanchez-Gomez DB, Hacisuleyman E, Li E, Spence M, Liapis SC, Mallard W, Morse M, Swerdel MR, D'Ecclessis MF, Moore JC, Lai V, Gong G, Yancopoulos GD, Frendewey D, Kellis M, Hart RP, Valenzuela DM, Arlotta P, Rinn JL (2013) Multiple knockout mouse models reveal lincRNAs are required for life and brain development. Elife 2:e01749. https://doi.org/10.7554/eLife.01749
Li K, Blum Y, Verma A, Liu Z, Pramanik K, Leigh NR, Chun CZ, Samant GV, Zhao B, Garnaas MK, Horswill MA, Stanhope SA, North PE, Miao RQ, Wilkinson GA, Affolter M, Ramchandran R (2010) A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo. Blood 115:133–139. https://doi.org/10.1182/blood-2009-09-242180
Kurian L, Aguirre A, Sancho-Martinez I, Benner C, Hishida T, Nguyen TB, Reddy P, Nivet E, Krause MN, Nelles DA, Esteban CR, Campistol JM, Yeo GW, Belmonte JCI (2015) Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development. Circulation 131:1278–1290. https://doi.org/10.1161/circulationaha.114.013303
Boulberdaa M, Scott E, Ballantyne M, Garcia R, Descamps B, Angelini GD, Brittan M, Hunter A, McBride M, McClure J, Miano JM, Emanueli C, Mills NL, Mountford JC, Baker AH (2016) A role for the long noncoding RNA SENCR in commitment and function of endothelial cells. Mol Ther 24:978–990. https://doi.org/10.1038/mt.2016.41
Michalik KM, You X, Manavski Y, Doddaballapur A, Zörnig M, Braun T, John D, Ponomareva Y, Chen W, Uchida S, Boon RA, Dimmeler S (2014) Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ Res 114:1389–1397. https://doi.org/10.1161/circresaha.114.303265
Boeckel JN, Jaé N, Heumüller AW, Chen W, Boon RA, Stellos K, Zeiher AM, John D, Uchida S, Dimmeler S (2015) Identification and characterization of hypoxia-regulated endothelial circular RNA. Circ Res 117:884–890. https://doi.org/10.1161/circresaha.115.306319
Wawrzyniak O, Zarebska Z, Rolle K, Gotz-Wieckowska A (2018) Circular and long non-coding RNAs and their role in ophthalmologic diseases. Acta Biochim Pol 65:497–508. https://doi.org/10.18388/abp.2018_2639
Leimena C, Qiu H (2018) Non-coding RNA in the pathogenesis, progression and treatment of hypertension. Int J Mol Sci. https://doi.org/10.3390/ijms19040927
Kapranov P, Cheng J, Dike S, Nix DA, Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermuller J, Hofacker IL, Bell I, Cheung E, Drenkow J, Dumais E, Patel S, Helt G, Ganesh M, Ghosh S, Piccolboni A, Sementchenko V, Tammana H, Gingeras TR (2007) RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 316:1484–1488. https://doi.org/10.1126/science.1138341
Amaral PP, Clark MB, Gascoigne DK, Dinger ME, Mattick JS (2011) lncRNAdb: a reference database for long noncoding RNAs. Nucleic Acids Res 39:D146–D151. https://doi.org/10.1093/nar/gkq1138
Parrott AM, Mathews MB (2007) Novel rapidly evolving hominid RNAs bind nuclear factor 90 and display tissue-restricted distribution. Nucleic Acids Res 35:6249–6258. https://doi.org/10.1093/nar/gkm668
Ahanda ML, Ruby T, Wittzell H, Bed'Hom B, Chausse AM, Morin V, Oudin A, Chevalier C, Young JR, Zoorob R (2009) Non-coding RNAs revealed during identification of genes involved in chicken immune responses. Immunogenetics 61:55–70. https://doi.org/10.1007/s00251-008-0337-8
Johnsson P, Lipovich L, Grander D, Morris KV (2014) Evolutionary conservation of long non-coding RNAs; sequence, structure, function. Biochim Biophys Acta 1840:1063–1071. https://doi.org/10.1016/j.bbagen.2013.10.035
Novikova IV, Hennelly SP, Sanbonmatsu KY (2013) Tackling structures of long noncoding RNAs. Int J Mol Sci 14:23672–23684. https://doi.org/10.3390/ijms141223672
Quinn JJ, Chang HY (2016) Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet 17:47–62. https://doi.org/10.1038/nrg.2015.10
Viereck J, Thum T (2017) Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ Res 120:381–399. https://doi.org/10.1161/circresaha.116.308434
Boon RA, Jaé N, Holdt L, Dimmeler S (2016) Long noncoding RNAs: from clinical genetics to therapeutic targets? J Am Coll Cardiol 67:1214–1226. https://doi.org/10.1016/j.jacc.2015.12.051
Agha G, Mendelson MM, Ward-Caviness CK, Joehanes R, Huan T, Gondalia R, Salfati E, Brody JA, Fiorito G, Bressler J, Chen BH, Ligthart S, Guarrera S, Colicino E, Just AC, Wahl S, Gieger C, Vandiver AR, Tanaka T, Hernandez DG, Pilling LC, Singleton AB, Sacerdote C, Krogh V, Panico S, Tumino R, Li Y, Zhang G, Stewart JD, Floyd JS, Wiggins KL, Rotter JI, Multhaup M, Bakulski K, Horvath S, Tsao PS, Absher DM, Vokonas P, Hirschhorn J, Fallin MD, Liu C, Bandinelli S, Boerwinkle E, Dehghan A, Schwartz JD, Psaty BM, Feinberg AP, Hou L, Ferrucci L, Sotoodehnia N, Matullo G, Peters A, Fornage M, Assimes TL, Whitsel EA, Levy D, Baccarelli AA (2019) Blood leukocyte DNA methylation predicts risk of future myocardial infarction and coronary heart disease. Circulation 140:645–657. https://doi.org/10.1161/circulationaha.118.039357
Arab K, Park YJ, Lindroth AM, Schäfer A, Oakes C, Weichenhan D, Lukanova A, Lundin E, Risch A, Meister M, Dienemann H, Dyckhoff G, Herold-Mende C, Grummt I, Niehrs C, Plass C (2014) Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Mol Cell 55:604–614. https://doi.org/10.1016/j.molcel.2014.06.031
Jia L, Wang Y, Wang C, Du Z, Zhang S, Wen X, Zhou L, Li H, Chen H, Li D, Zhang S, Li W, Xu W, Hoffman AR, Cui J, Hu JF (2020) Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylation. Nucleic Acids Res 48:3935–3948. https://doi.org/10.1093/nar/gkaa097
Xu H, Jiang Y, Xu X, Su X, Liu Y, Ma Y, Zhao Y, Shen Z, Huang B (2019) Inducible degradation of lncRNA Sros1 promotes IFN-γ-mediated activation of innate immune responses by stabilizing Stat1 mRNA. Nat Immunol 20:1621–1630. https://doi.org/10.1038/s41590-019-0542-7
Geisler S, Coller J (2013) RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 14:699–712. https://doi.org/10.1038/nrm3679
Kim C, Kang D, Lee EK, Lee J-S (2017) Long Noncoding RNAs and RNA-binding proteins in oxidative stress, cellular senescence, and age-related diseases. Oxid Med Cell Longev 2017:2062384–2062384. https://doi.org/10.1155/2017/2062384
Wang X, Shen C, Zhu J, Shen G, Li Z, Dong J (2019) Long noncoding RNAs in the regulation of oxidative stress. Oxid Med Cell Longev 2019:1318795–1318795. https://doi.org/10.1155/2019/1318795
Xiao Y, Pan J, Geng Q, Wang G (2019) LncRNA MALAT1 increases the stemness of gastric cancer cells via enhancing SOX2 mRNA stability. FEBS Open Biol 9:1212–1222. https://doi.org/10.1002/2211-5463.12649
Yoon JH, Abdelmohsen K, Kim J, Yang X, Martindale JL, Tominaga-Yamanaka K, White EJ, Orjalo AV, Rinn JL, Kreft SG, Wilson GM, Gorospe M (2013) Scaffold function of long non-coding RNA HOTAIR in protein ubiquitination. Nat Commun 4:2939. https://doi.org/10.1038/ncomms3939
Hu W, Bi ZY, Chen ZL, Liu C, Li LL, Zhang F, Zhou Q, Zhu W, Song YY, Zhan BT, Zhang Q, Bi YY, Sun CC, Li DJ (2018) Emerging landscape of circular RNAs in lung cancer. Cancer Lett 427:18–27. https://doi.org/10.1016/j.canlet.2018.04.006
Hsiao KY, Sun HS, Tsai SJ (2017) Circular RNA—New member of noncoding RNA with novel functions. Exp Biol Med (Maywood) 242:1136–1141. https://doi.org/10.1177/1535370217708978
Lasda E, Parker R (2014) Circular RNAs: diversity of form and function. RNA 20:1829–1842. https://doi.org/10.1261/rna.047126.114
Hermans-Beijnsberger S, van Bilsen M, Schroen B (2018) Long non-coding RNAs in the failing heart and vasculature. Noncoding RNA Res 3:118–130. https://doi.org/10.1016/j.ncrna.2018.04.002
Greene J, Baird AM, Brady L, Lim M, Gray SG, McDermott R, Finn SP (2017) Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci 4:38. https://doi.org/10.3389/fmolb.2017.00038
Qu S, Yang X, Li X, Wang J, Gao Y, Shang R, Sun W, Dou K, Li H (2015) Circular RNA: a new star of noncoding RNAs. Cancer Lett 365:141–148. https://doi.org/10.1016/j.canlet.2015.06.003
Han YN, Xia SQ, Zhang YY, Zheng JH, Li W (2017) Circular RNAs: a novel type of biomarker and genetic tools in cancer. Oncotarget 8:64551–64563. https://doi.org/10.18632/oncotarget.18350
Dong Y, He D, Peng Z, Peng W, Shi W, Wang J, Li B, Zhang C, Duan C (2017) Circular RNAs in cancer: an emerging key player. J Hematol Oncol 10:2. https://doi.org/10.1186/s13045-016-0370-2
Lopez-Jimenez E, Rojas AM, Andres-Leon E (2018) RNA sequencing and prediction tools for circular RNAs analysis. Adv Exp Med Biol 1087:17–33. https://doi.org/10.1007/978-981-13-1426-1_2
Holdt LM, Stahringer A, Sass K, Pichler G, Kulak NA, Wilfert W, Kohlmaier A, Herbst A, Northoff BH, Nicolaou A, Gäbel G, Beutner F, Scholz M, Thiery J, Musunuru K, Krohn K (2016) Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun 7:12429. https://doi.org/10.1038/ncomms12429
Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, Evantal N, Memczak S, Rajewsky N, Kadener S (2014) circRNA biogenesis competes with pre-mRNA splicing. Mol Cell 56:55–66. https://doi.org/10.1016/j.molcel.2014.08.019
Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB (2016) Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res 44:2846–2858. https://doi.org/10.1093/nar/gkw027
Xu W, Erzurum SC (2011) Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension. Compr Physiol 1:357–372. https://doi.org/10.1002/cphy.c090005
Ding S, Zhu Y, Liang Y, Huang H, Xu Y, Zhong C (2018) Circular RNAs in vascular functions and diseases. Adv Exp Med Biol 1087:287–297. https://doi.org/10.1007/978-981-13-1426-1_23
Liu Y, Zhang R, Ying K (2015) Long noncoding RNAs: novel links in respiratory diseases (review). Mol Med Rep 11:4025–4031. https://doi.org/10.3892/mmr.2015.3290
Comer BS, Ba M, Singer CA, Gerthoffer WT (2015) Epigenetic targets for novel therapies of lung diseases. Pharmacol Ther 147:91–110. https://doi.org/10.1016/j.pharmthera.2014.11.006
Zhang J, Zhu Y, Wang R (2018) Long noncoding RNAs in respiratory diseases. Histol Histopathol 33:747–756. https://doi.org/10.14670/hh-11-966
Coll-Bonfill N, de la Cruz-Thea B, Pisano MV, Musri MM (2016) Noncoding RNAs in smooth muscle cell homeostasis: implications in phenotypic switch and vascular disorders. Pflugers Arch 468:1071–1087. https://doi.org/10.1007/s00424-016-1821-x
Gu S, Li G, Zhang X, Yan J, Gao J, An X, Liu Y, Su P (2015) Aberrant expression of long noncoding RNAs in chronic thromboembolic pulmonary hypertension. Mol Med Rep 11:2631–2643. https://doi.org/10.3892/mmr.2014.3102
Leisegang MS, Fork C, Josipovic I, Richter FM, Preussner J, Hu J, Miller MJ, Epah J, Hofmann P, Gunther S, Moll F, Valasarajan C, Heidler J, Ponomareva Y, Freiman TM, Maegdefessel L, Plate KH, Mittelbronn M, Uchida S, Kunne C, Stellos K, Schermuly RT, Weissmann N, Devraj K, Wittig I, Boon RA, Dimmeler S, Pullamsetti SS, Looso M, Miller FJ Jr, Brandes RP (2017) Long noncoding RNA MANTIS facilitates endothelial angiogenic function. Circulation 136:65–79. https://doi.org/10.1161/circulationaha.116.026991
Josipovic I, Fork C, Preussner J, Prior KK, Iloska D, Vasconez AE, Labocha S, Angioni C, Thomas D, Ferreiros N, Looso M, Pullamsetti SS, Geisslinger G, Steinhilber D, Brandes RP, Leisegang MS (2016) PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cells. Acta Physiol (Oxf) 218:13–27. https://doi.org/10.1111/apha.12700
Zhuo Y, Zeng Q, Zhang P, Li G, Xie Q, Cheng Y (2017) Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people. Clin Chem Lab Med 55:38–46. https://doi.org/10.1515/cclm-2016-0056
Jiang X, Ning Q (2020) Long noncoding RNAs as novel players in the pathogenesis of hypertension. Hypertens Res. https://doi.org/10.1038/s41440-020-0408-2
Jiang X, Lei R, Ning Q (2016) Circulating long noncoding RNAs as novel biomarkers of human diseases. Biomark Med 10:757–769. https://doi.org/10.2217/bmm-2016-0039
Jiang X, Ning Q (2015) The emerging roles of long noncoding RNAs in common cardiovascular diseases. Hypertens Res 38:375–379. https://doi.org/10.1038/hr.2015.26
Xue YZ, Li ZJ, Liu WT, Shan JJ, Wang L, Su Q (2019) Down-regulation of lncRNA MALAT1 alleviates vascular lesion and vascular remodeling of rats with hypertension. Aging (Albany NY) 11:5192–5205. https://doi.org/10.18632/aging.102113
Chen R, Chen S, Zhang T, Lin J, Wan C, Chen Z, Li H, Ding Y, Wu S (2017) Relationships among long noncoding RNA, environmental factors and hypertension. Wei Sheng Yan Jiu 46:905–912
Yu J, Yang Y, Xu Z, Lan C, Chen C, Li C, Chen Z, Yu C, Xia X, Liao Q, Jose PA, Zeng C, Wu G (2020) Long noncoding RNA ahit protects against cardiac hypertrophy through SUZ12 (Suppressor of Zeste 12 protein homolog)-mediated downregulation of MEF2A (Myocyte Enhancer Factor 2A). Circ Heart Fail 13:e006525. https://doi.org/10.1161/circheartfailure.119.006525
Du SS, Zuo XJ, Xin Y, Man JX, Wu ZL (2020) Expression of lncRNA TUG1 in hypertensive patients and its relationship with change state of an illness. Eur Rev Med Pharmacol Sci 24:870–877. https://doi.org/10.26355/eurrev_202001_20071
Bayoglu B, Yuksel H, Cakmak HA, Dirican A, Cengiz M (2016) Polymorphisms in the long non-coding RNA CDKN2B-AS1 may contribute to higher systolic blood pressure levels in hypertensive patients. Clin Biochem 49:821–827. https://doi.org/10.1016/j.clinbiochem.2016.02.012
Vausort M, Wagner DR, Devaux Y (2014) Long noncoding RNAs in patients with acute myocardial infarction. Circ Res 115:668–677. https://doi.org/10.1161/circresaha.115.303836
Guo F, Tang C, Li Y, Liu Y, Lv P, Wang W, Mu Y (2018) The interplay of LncRNA ANRIL and miR-181b on the inflammation-relevant coronary artery disease through mediating NF-kappaB signalling pathway. J Cell Mol Med 22:5062–5075. https://doi.org/10.1111/jcmm.13790
Gopalakrishnan K, Kumarasamy S, Mell B, Joe B (2015) Genome-wide identification of long noncoding RNAs in rat models of cardiovascular and renal disease. Hypertension 65:200–210. https://doi.org/10.1161/hypertensionaha.114.04498
Wang F, Li L, Xu H, Liu Y, Yang C, Cowley AW Jr, Wang N, Liu P, Liang M (2014) Characteristics of long non-coding RNAs in the Brown Norway rat and alterations in the Dahl salt-sensitive rat. Sci Rep 4:7146. https://doi.org/10.1038/srep07146
Wu H, Zhu S, Yuan R, Yi Y, Wang H, Gu B, Zhen T (2019) Transcriptome sequencing to detect the potential role of long noncoding RNAs in salt-sensitive hypertensive rats. Biomed Res Int 2019:2816959. https://doi.org/10.1155/2019/2816959
Hou L, Lin Z, Ni Y, Wu Y, Chen D, Song L, Huang X, Hu H, Yang D (2016) Microarray expression profiling and gene ontology analysis of long non-coding RNAs in spontaneously hypertensive rats and their potential roles in the pathogenesis of hypertension. Mol Med Rep 13:295–300. https://doi.org/10.3892/mmr.2015.4554
Lu Q, Meng Q, Qi M, Li F, Liu B (2019) Shear-sensitive lncRNA AF131217.1 inhibits inflammation in HUVECs via regulation of KLF4. Hypertension 73:e25–e34. https://doi.org/10.1161/hypertensionaha.118.12476
Wang YN, Shan K, Yao MD, Yao J, Wang JJ, Li X, Liu B, Zhang YY, Ji Y, Jiang Q, Yan B (2016) Long noncoding RNA-GAS5: a novel regulator of hypertension-induced vascular remodeling. Hypertension 68:736–748. https://doi.org/10.1161/hypertensionaha.116.07259
Yin Q, Wu A, Liu M (2017) Plasma long non-coding RNA (lncRNA) GAS5 is a new biomarker for coronary artery disease. Med Sci Monit 23:6042–6048. https://doi.org/10.12659/msm.907118
Zhuo X, Wu Y, Yang Y, Gao L, Qiao X, Chen T (2019) LncRNA AK094457 promotes AngII-mediated hypertension and endothelial dysfunction through suppressing of activation of PPARgamma. Life Sci 233:116745. https://doi.org/10.1016/j.lfs.2019.116745
Xu J, Sun Y, Lu J (2020) Knockdown of long noncoding RNA (lncRNA) AK094457 relieved angiotensin II induced vascular endothelial cell injury. Med Sci Monit 26:e919854. https://doi.org/10.12659/msm.919854
Zhang X, Yang X, Lin Y, Suo M, Gong L, Chen J, Hui R (2015) Anti-hypertensive effect of Lycium barbarum L. with down-regulated expression of renal endothelial lncRNA sONE in a rat model of salt-sensitive hypertension. Int J Clin Exp Pathol 8:6981–6987
Yang Y, Xi P, Xie Y, Zhao C, Xu J, Jiang J (2015) Notoginsenoside R1 reduces blood pressure in spontaneously hypertensive rats through a long non-coding RNA AK094457. Int J Clin Exp Pathol 8:2700–2709
Miao R, Wang Y, Wan J, Leng D, Gong J, Li J, Liang Y, Zhai Z, Yang Y (2017) Microarray expression profile of circular RNAs in chronic thromboembolic pulmonary hypertension. Medicine (Baltimore) 96:e7354. https://doi.org/10.1097/md.0000000000007354
Miao R, Gong J, Zhang C, Wang Y, Guo X, Li J, Yang S, Kuang T, Zhong J, Feng H (2019) Hsa_circ_0046159 is involved in the development of chronic thromboembolic pulmonary hypertension. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-019-01998-4
Wang J, Zhu MC, Kalionis B, Wu JZ, Wang LL, Ge HY, Chen CC, Tang XD, Song YL, He H, Xia SJ (2018) Characteristics of circular RNA expression in lung tissues from mice with hypoxiainduced pulmonary hypertension. Int J Mol Med 42:1353–1366. https://doi.org/10.3892/ijmm.2018.3740
Zhou S, Jiang H, Li M, Wu P, Sun L, Liu Y, Zhu K, Zhang B, Sun G, Cao C, Wang R (2019) Circular RNA hsa_circ_0016070 is associated with pulmonary arterial hypertension by promoting PASMC proliferation. Mol Ther Nucleic Acids 18:275–284. https://doi.org/10.1016/j.omtn.2019.08.026
Wu N, Jin L, Cai J (2017) Profiling and bioinformatics analyses reveal differential circular RNA expression in hypertensive patients. Clin Exp Hypertens 39:454–459. https://doi.org/10.1080/10641963.2016.1273944
Bao X, Zheng S, Mao S, Gu T, Liu S, Sun J, Zhang L (2018) A potential risk factor of essential hypertension in case-control study: circular RNA hsa_circ_0037911. Biochem Biophys Res Commun 498:789–794. https://doi.org/10.1016/j.bbrc.2018.03.059
Zheng S, Gu T, Bao X, Sun J, Zhao J, Zhang T, Zhang L (2019) Circular RNA hsa_circ_0014243 may serve as a diagnostic biomarker for essential hypertension. Exp Ther Med 17:1728–1736. https://doi.org/10.3892/etm.2018.7107
Bao X, He X, Zheng S, Sun J, Luo Y, Tan R, Zhao J, Zhong F, Zhang L (2019) Up-regulation of circular RNA hsa_circ_0037909 promotes essential hypertension. J Clin Lab Anal 33:e22853. https://doi.org/10.1002/jcla.22853
Liu L, Gu T, Bao X, Zheng S, Zhao J, Zhang L (2019) Microarray profiling of circular RNA identifies hsa_circ_0126991 as a potential risk factor for essential hypertension. Cytogenet Genome Res 157:203–212. https://doi.org/10.1159/000500063
Liu C, Yao MD, Li CP, Shan K, Yang H, Wang JJ, Liu B, Li XM, Yao J, Jiang Q, Yan B (2017) Silencing of circular RNA-ZNF609 ameliorates vascular endothelial dysfunction. Theranostics 7:2863–2877. https://doi.org/10.7150/thno.19353
Zhang Z, Zhang T, Feng R, Huang H, Xia T, Sun C (2019) circARF3 alleviates mitophagy-mediated inflammation by targeting miR-103/TRAF3 in mouse adipose tissue. Mol Ther Nucleic Acids 14:192–203. https://doi.org/10.1016/j.omtn.2018.11.014
Nosalski R, Guzik TJ (2017) Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol 174:3496–3513. https://doi.org/10.1111/bph.13705
Zhang X, Li DY, Reilly MP (2019) Long intergenic noncoding RNAs in cardiovascular diseases: challenges and strategies for physiological studies and translation. Atherosclerosis 281:180–188. https://doi.org/10.1016/j.atherosclerosis.2018.09.040
Uchida S, Dimmeler S (2015) Long noncoding RNAs in cardiovascular diseases. Circ Res 116:737–750. https://doi.org/10.1161/circresaha.116.302521
Durruthy-Durruthy J, Sebastiano V, Wossidlo M, Cepeda D, Cui J (2016) The primate-specific noncoding RNA HPAT5 regulates pluripotency during human preimplantation development and nuclear reprogramming. Nat Genet 48:44–52. https://doi.org/10.1038/ng.3449
Acknowledgements
This work was supported by grants from the Fund of the National Natural Science Foundation of China (81700364), Jiangsu Natural Science Foundation (BK20170179, BK20191138), Key Young Medical Talent Project of Jiangsu Health Commission (QNRC2016158), Jiangsu Province Department of Science and Technology (BE2020634), Project funded by China Postdoctoral Science Foundation (2017M611688) and Project funded by Jiangsu Postdoctoral Science Foundation (1701062C).
Author information
Authors and Affiliations
Contributions
JRZ, and HJS consulted the literature, wrote and reviewed the manuscript. All authors approved the final version for submission.
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no conflict of interest.
Research involving human participants and/or animals
The present article does not contain human participants and/or animals.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, JR., Sun, HJ. LncRNAs and circular RNAs as endothelial cell messengers in hypertension: mechanism insights and therapeutic potential. Mol Biol Rep 47, 5535–5547 (2020). https://doi.org/10.1007/s11033-020-05601-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-020-05601-5